amikacin has been researched along with Bacterial Pneumonia in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (20.00) | 18.2507 |
| 2000's | 27 (41.54) | 29.6817 |
| 2010's | 19 (29.23) | 24.3611 |
| 2020's | 6 (9.23) | 2.80 |
| Authors | Studies |
|---|---|
| Igartua, M; Maria Hernandez, R; Vairo, C; Villar Vidal, M; Villullas, S | 1 |
| Ardanuy, C; Càmara, J; Cilloniz, C; Ercibengoa, M; Galar, A; García-Olivé, I; García-Somoza, D; Marimón, JM; Marin, M; Martín-Rabadán, P; Mateu, L; Muñoz, P; Pedro-Botet, ML; Prat, C; Torres, A; Tubau, F | 1 |
| Kalil, AC; Sweeney, DA | 1 |
| Nambiar, S; Schumann, K; Walinsky, S | 1 |
| Du, B; Huang, HB; Qin, JP; Xu, Y; Zhou, H; Zhu, Y | 1 |
| Gu, KM; Kim, JY; Kwak, N; Park, J; Yim, JJ; Yoon, SH | 1 |
| Arnaud, E; Larcher, R; Lavigne, JP; Pantel, A; Sotto, A | 1 |
| Asakura, T; Asami, T; Betsuyaku, T; Fujiwara, H; Funatsu, Y; Hasegawa, N; Iketani, O; Ishii, M; Kamo, T; Namkoong, H; Nishimura, T; Sugiura, H; Suzuki, S; Tasaka, S; Uwamino, Y; Yagi, K; Yamada, Y | 1 |
| Abbassi, MM; Awdallah, FF; Hassan, NA; Sabry, NA | 1 |
| Allegrini, F; Cravero, P; Delmonte, A; Diano, D; Fausti, V; Frassineti, GL; Marcantognini, G; Monti, M | 1 |
| Schreiber, MP; Shorr, AF | 1 |
| Goldberg, D; Pacheco, JM | 1 |
| Birkun, AA; Fedosov, MI; Krivorutchenko, YL; Kubyshkin, AV; Novikov, NY; Postnikova, ON; Snitser, AA | 1 |
| Aubert, C; Barbar, S; Bastide, S; Elotmani, L; Lefrant, JY; Lloret, S; Molinari, N; Muller, L; Nucci, B; Polge, A; Pradel, G; Roberts, JA; Roger, C; Saissi, G | 1 |
| Clancy, JP; Ehsan, Z | 1 |
| Gunasekaran, J; Shariff, M | 1 |
| Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N | 1 |
| Kiefer, I; Krautwald-Junghanns, ME; Oechtering, G; Pees, M | 1 |
| Chaudhary, M; Sehgal, R; Shrivastava, SM; Varughese, L | 1 |
| Chaudhary, M; Dwivedi, VK; Shrivastava, SM; Singh, CP; Soni, A | 1 |
| Hou, J; Ledesma, KR; Prince, RA; Singh, R; Tam, VH; Yuan, Z | 1 |
| Asensi, MD; Carvalho-Assef, AP; Correal, JC; Goldemberg, DC; Leão, RS; Marques, EA; Silva, RV | 1 |
| Chastre, J; Corkery, K; Eldon, MA; Gribben, D; Luyt, CE; Stass, H | 1 |
| Chastre, J; Corkery, K; Fink, JB; García, MS; Luyt, CE; Niederman, MS | 1 |
| Safdar, A | 1 |
| Aboussad, A; Chabaa, L; Elidrissi, NS; Issaoui, S; Maoulainine, FM; Sorra, N | 1 |
| Chaumais, MC; Jacolot, A; Judel, C; Louchahi, K; Marchand, S; Mimoz, O; Nicolas, P; Petitjean, O | 1 |
| Aarnoutse, RE; Boeree, MJ; Daley, CL; Egelund, EF; Heifets, LB; Levin, A; Mouton, JW; Peloquin, CA; Totten, SE; van Ingen, J | 1 |
| Ferrari, F; Goldstein, I; Marquette, CH; Nicolas-Robin, A; Rouby, JJ; Wallet, F | 1 |
| Dhingra, VK; Gorman, SK; Ronco, JJ; Zed, PJ | 1 |
| Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
| Ayar, M; Crevon, T; Falque, L; Herve, V; Koninck, JC; L'Her, P; Le Vagueresse, R; Samson, T; Simon, F; Vaylet, F | 1 |
| Perederko, LV; Polikarpova, SV; Postnikov, SS; Semykin, SIu | 1 |
| De Almeida, JF; De Sá, FR; Sztajnbok, J; Troster, EJ; Vaz, FA | 1 |
| Bargon, J; Böddinghaus, B; Frickmann, H; Jungblut, S | 1 |
| Bernabeu-Wittel, M; García-Curiel, A; Ibáñez-Martínez, J; Jiménez-Mejías, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C | 1 |
| Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A | 1 |
| Borchers, M; Teikemeier, F; Theegarten, D; von der Mülbe, B | 1 |
| Brumble, L; Garland, JL; Johnson, MM; Khoor, A; Roy, A; Waller, EA | 1 |
| Ayyagari, A; Dash, NR; Ghar, M; Nag, VL; Prasad, KN; Venkatesh, V | 1 |
| Asaoka, N; Honda, Y; Kibayashi, T; Kishimoto, M; Kurihara, T; Nanba, F; Okimoto, N; Osaki, K; Yamato, K | 1 |
| Akin, ES; Bilgiç, H; Ekiz, K; Seber, O; Taşan, Y | 1 |
| Beaucaire, G; Beuscart, C; Buguin, D; Georges, H; Jacquier, JM; Leroy, O; Santré, C | 1 |
| Colardyn, F | 1 |
| Covi, M; Velluti, G | 1 |
| Beaucaire, G | 1 |
| Arrouet-Lagandre, C; Ategbo, S; Deschildre, A; Druon, D; Elian, JC; Farriaux, JP; Husson, MO; Loeuille, GA; Tassin, E; Turck, D; Vic, P | 1 |
| Caillon, J; Jacolot, A; Louchahi, K; Mimoz, O; Padoin, C; Petitjean, O; Samii, K; Tod, M | 1 |
| Brière, S; Brun-Buisson, C; Petit, C; Schweich, H; Sollet, JP | 1 |
| Jacolot, A; Mimoz, O; Padoin, C; Petitjean, O; Samii, K; Tod, M | 1 |
| Bollas, G; Dervenoulas, JG; Pappa, V; Raptis, S; Tsirigotis, P | 1 |
| Beaucaire, G; Holzapfel, L; Le Fur, D; Léophonte, P; Martin, C; Nicolas, MH; Offenstadt, G; Péan, Y; Philippon, A; Renard, S | 1 |
| Elhelali, N; Jacolot, A; Laurent, F; Léotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K | 1 |
| Caballero, FJ; Cuberos, L; García-Curiel, A; Ibáñez-Martínez, J; Jiménez-Mejías, ME; Moreno, I; Pachón, J; Pichardo, C; Rodríguez-Hernández, MJ | 1 |
| Aoki, K; Asano, S; Bessho, M; Fujita, A; Furusawa, S; Higashihara, M; Hirai, H; Hoshino, S; Hotta, T; Kitamura, K; Koike, M; Kuraishi, Y; Kurihara, I; Mizoguchi, H; Nagoshi, H; Nishimura, M; Nonaka, Y; Ohbayashi, Y; Omine, M; Oshimi, K; Ozawa, K; Suzuki, K; Takaku, F; Togawa, A; Urabe, A; Wakabayashi, Y | 1 |
| Bryskier, A; Carbon, C; Farinotti, R; Joly-Guillou, ML; Wolff, M | 1 |
| Alvarez Lerma, F | 2 |
| Aliff, CL; Standridge, JB | 1 |
| Abi-Said, D; Bivins, C; Hachem, R; Hanna, H; Huaringa, A; Raad, I; Sukumaran, A; Thornby, J; Walsh, G; Whimbey, E | 1 |
| Alvarez-Lerma, F; Barcenilla, F; Insausti-Ordeñana, J; Jordá-Marcos, R; Maraví-Poma, E; Martínez-Pellús, A; Nava, J; Palomar, M; Torres-Martí, A | 1 |
| Delatour, F; Faurisson, F; Jelazko, P | 1 |
| Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
| Báñez, F; Biechy, M; Gálvez, E; Salgueró, E | 1 |
5 review(s) available for amikacin and Bacterial Pneumonia
| Article | Year |
|---|---|
Colistin- and amikacin-loaded lipid-based drug delivery systems for resistant gram-negative lung and wound bacterial infections.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Colistin; Drug Delivery Systems; Drug Resistance, Multiple, Bacterial; Humans; Liposomes; Lung; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Wound Infection | 2023 |
Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Critical Care; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Respiration, Artificial; Treatment Outcome | 2021 |
Inhaled antibiotics for the treatment of pneumonia.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated | 2019 |
Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.
Topics: Administration, Inhalation; Aerosols; Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Drug Carriers; Humans; Liposomes; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections | 2015 |
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2005 |
19 trial(s) available for amikacin and Bacterial Pneumonia
| Article | Year |
|---|---|
Nebulized Versus IV Amikacin as Adjunctive Antibiotic for Hospital and Ventilator-Acquired Pneumonia Postcardiac Surgeries: A Randomized Controlled Trial.
Topics: Administration, Inhalation; Adult; Amikacin; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Heart Diseases; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Postoperative Complications; Prospective Studies; Treatment Outcome | 2018 |
Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Drug Combinations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas Infections; Treatment Outcome | 2008 |
Pharmacokinetics and tolerability of amikacin administered as BAY41-6551 aerosol in mechanically ventilated patients with gram-negative pneumonia and acute renal failure.
Topics: Acute Kidney Injury; Aerosols; Aged; Amikacin; Anti-Bacterial Agents; Area Under Curve; Critical Illness; Drug Delivery Systems; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Hemodiafiltration; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Tissue Distribution | 2011 |
BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia.
Topics: Aerosols; Amikacin; Anti-Bacterial Agents; Body Fluids; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Respiration, Artificial; Trachea | 2012 |
[Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Treatment Outcome | 2003 |
Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bronchi; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Respiratory Insufficiency | 1995 |
The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
Topics: Acute Disease; Amikacin; Anti-Bacterial Agents; Bronchitis; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections; Retrospective Studies | 1995 |
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 1995 |
Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 1995 |
Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Audiometry; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Schedule; Female; Humans; Infant; Kidney Function Tests; Male; Pneumonia, Bacterial; Pseudomonas Infections | 1996 |
Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Consumer Product Safety; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Population; Treatment Failure; Ventilators, Mechanical | 1998 |
[The clinical manifestation and drug sensitive tests of lower respiratory tract infection by enterobacter cloacae. The Pulmonary Infection and Fibrosis Group, Thoracic Society Shanghai Medical Association].
Topics: Adult; Aged; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Imipenem; Lung Diseases, Obstructive; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections | 1997 |
[Phare study. Comparative study of combined cefepime-amikacin versus ceftazidime combined with amikacin in the treatment of nosocomial pneumonias in ventilated patients. Multicenter group study].
Topics: Amikacin; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Survival Rate | 1999 |
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia, Bacterial; Sepsis | 2000 |
Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia.
Topics: Aged; Amikacin; Analysis of Variance; Ceftazidime; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Prospective Studies; Respiration, Artificial; Thienamycins; Treatment Outcome | 2001 |
Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study.
Topics: Aged; Amikacin; Aztreonam; Chi-Square Distribution; Clindamycin; Cross Infection; Drug Therapy, Combination; Humans; Middle Aged; Neoplasms; Opportunistic Infections; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Postoperative Complications; Prognosis; Prospective Studies; Tazobactam | 2001 |
Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
Topics: Aged; Amikacin; Ceftazidime; Cephalosporins; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Hospital Mortality; Hospitals, Teaching; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Proportional Hazards Models; Prospective Studies; Spain; Survival Analysis; Treatment Outcome | 2001 |
A simple tool for monitoring nebulized amikacin treatments based on a single urine assay.
Topics: Administration, Inhalation; Adult; Amikacin; Creatinine; Cystic Fibrosis; Drug Monitoring; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Bacterial; Pseudomonas Infections; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2001 |
[Efficacy of monotherapy by meropenem in ventilator-associated pneumonia].
Topics: Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Respiration, Artificial; Superinfection; Thienamycins | 2001 |
41 other study(ies) available for amikacin and Bacterial Pneumonia
| Article | Year |
|---|---|
A multicentre analysis of Nocardia pneumonia in Spain: 2010-2016.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Middle Aged; Nocardia; Nocardia Infections; Pneumonia, Bacterial; Retrospective Studies; Spain; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2020 |
The last breath for inhaled antibiotics and VAP? Not so fast.
Topics: Amikacin; Anti-Bacterial Agents; Double-Blind Method; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Respiration, Artificial | 2020 |
FDA's Limited Population Pathway for Antibacterial and Antifungal Drugs.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cross Infection; Drug Approval; Drug Resistance, Microbial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Liposomes; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Nitroimidazoles; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sisomicin; United States; United States Food and Drug Administration | 2021 |
Radiographic severity and treatment outcome of Mycobacterium abscessus complex pulmonary disease.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefoxitin; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Radiography, Thoracic; Retrospective Studies; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
First report of cavitary pneumonia due to community-acquired Acinetobacter pittii, study of virulence and overview of pathogenesis and treatment.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Animals; Caenorhabditis elegans; Community-Acquired Infections; Cross Infection; Female; France; Humans; Middle Aged; Multilocus Sequence Typing; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Virulence | 2017 |
The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases.
Topics: Administration, Inhalation; Aged; Amikacin; Cough; Drug Therapy, Combination; Female; Humans; Japan; Male; Middle Aged; Mycobacterium; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Retrospective Studies; Sputum; Thorax; Treatment Outcome | 2017 |
Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection.
Topics: Amikacin; Anti-Bacterial Agents; Bordetella bronchiseptica; Bordetella Infections; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Cough; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonia, Bacterial | 2017 |
A curious cause of cavitations: Nocardia pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Bronchoscopy; Clindamycin; Comorbidity; Fever; Hemoptysis; Humans; Imipenem; Immunocompromised Host; Lung Abscess; Male; Middle Aged; Neuroimaging; Nocardia Infections; Pneumonia, Bacterial; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Weight Loss | 2014 |
Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas-Induced Pneumonia.
Topics: Administration, Inhalation; Amikacin; Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Drug Combinations; Lung; Male; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Surfactants; Rats, Wistar | 2015 |
Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cohort Studies; Critical Illness; Female; Gentamicins; Humans; Intraabdominal Infections; Male; Middle Aged; Plasma; Pneumonia, Bacterial; Urinary Tract Infections | 2015 |
Pulmonary Nocardiosis: Review of Cases and an Update.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cough; Diabetes Mellitus; Dyspnea; Female; Humans; Imipenem; Immunocompromised Host; India; Male; Meropenem; Middle Aged; Nocardia Infections; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary | 2016 |
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam | 2016 |
Computed tomography for the diagnosis and treatment monitoring of bacterial pneumonia in Indian pythons (Python molurus).
Topics: Amikacin; Animals; Anti-Bacterial Agents; Boidae; Ceftazidime; Enrofloxacin; Fluoroquinolones; Humans; Lung; Male; Pneumonia, Bacterial; Tomography, Spiral Computed; Treatment Outcome | 2008 |
Fixed-dose combination of cefepime plus amikacin (potentox) inhibits pneumonia infection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Catalase; Cefepime; Cephalosporins; Drug Therapy, Combination; Klebsiella Infections; Klebsiella pneumoniae; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Pneumonia, Bacterial; Rats; Rats, Wistar; Superoxide Dismutase | 2009 |
Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model.
Topics: Acinetobacter baumannii; Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cephalosporins; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Lung; Mice; Ofloxacin; Pneumonia, Bacterial; Polymerase Chain Reaction; Pseudomonas aeruginosa; Random Allocation; Survival Analysis | 2010 |
KPC-2 producing Klebsiella pneumoniae and Escherichia coli co-infection in a catheter-related infection.
Topics: Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Catheter-Related Infections; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pneumonia, Bacterial; Thienamycins | 2011 |
Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis.
Topics: Aerosols; Aged; Amikacin; Anti-Bacterial Agents; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Treatment Outcome | 2012 |
[Neonatal infection with Stenotrophomonas maltophilia (2 case studies)].
Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Chloramphenicol; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Echoencephalography; Empyema, Subdural; Fatal Outcome; Female; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Pneumonia, Bacterial; Sepsis; Stenotrophomonas maltophilia; Thiamphenicol; Tomography, X-Ray Computed | 2012 |
Animal model methodology: immunocompetent or leucopenic rats, which is the best? Results from a model of experimental pneumonia due to derepressed cephalosporinase-producing Enterobacter cloacae.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cephalosporinase; Cephalosporins; Cyclophosphamide; Drug Therapy, Combination; Enterobacter cloacae; Immunocompromised Host; Injections, Intraperitoneal; Leukopenia; Male; Models, Animal; Pneumonia, Bacterial; Rats; Rats, Wistar | 2012 |
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
Topics: Adult; Aged; Amikacin; Antibiotics, Antitubercular; Area Under Curve; Clarithromycin; Cohort Studies; Colorado; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Retrospective Studies; Rifabutin; Rifampin | 2012 |
Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets.
Topics: Administration, Inhalation; Amikacin; Animals; Anti-Bacterial Agents; Bronchopneumonia; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli Infections; Injections, Intravenous; Lung; Nebulizers and Vaporizers; Pneumonia, Bacterial; Respiration, Artificial; Severity of Illness Index; Swine; Treatment Outcome | 2002 |
Rapid imipenem/cilastatin desensitization for multidrug-resistant Acinetobacter pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Male; Pneumonia, Bacterial; Protease Inhibitors | 2003 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
[Thoracic nocardiasis associated with macrophage activation syndrome].
Topics: AIDS-Related Opportunistic Infections; Amikacin; Arthritis, Infectious; Biopsy; Bone Marrow; Ceftriaxone; Diagnosis, Differential; Drug Resistance, Multiple; Drug Therapy, Combination; Histiocytosis, Non-Langerhans-Cell; Humans; Lung; Macrophage Activation; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia asteroides; Nocardia Infections; Pneumonia, Bacterial; Recurrence; Synovial Membrane; Systemic Inflammatory Response Syndrome; Tomography, X-Ray Computed | 2001 |
Listeria monocytogenes pneumonia in a cirrhotic child.
Topics: Adolescent; Amikacin; Ampicillin; Anti-Bacterial Agents; Female; Humans; Listeria monocytogenes; Listeriosis; Liver Cirrhosis; Pleural Effusion; Pneumonia, Bacterial | 2004 |
[Pneumonia induced by nocardia -- a case report].
Topics: Amikacin; Drug Therapy, Combination; Humans; Imipenem; Male; Middle Aged; Nocardia; Nocardia Infections; Pneumonia, Bacterial; Polymerase Chain Reaction; Treatment Outcome | 2004 |
Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Guinea Pigs; Imipenem; Lung; Microbial Sensitivity Tests; Pneumonia, Bacterial | 2005 |
[Pulmonary nocardiasis with abscesses spreading to cerebrum, cerebellum and orbits].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Biopsy, Needle; Brain Abscess; Cerebellar Diseases; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Imipenem; Lung Abscess; Magnetic Resonance Imaging; Nocardia Infections; Orbital Diseases; Pneumonia, Bacterial; Tomography, X-Ray Computed; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease.
Topics: Adult; Amikacin; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Lung; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Prednisone; Rifampin; Sputum; Tomography, X-Ray Computed | 2006 |
Bacterial isolates from mechanically ventilated patients with nosocomial pneumonia within intensive care unit of a tertiary care center.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cross Infection; Humans; Intensive Care Units; Pneumonia, Bacterial; Respiration, Artificial | 2005 |
[Study of the cases with multidrug-resistant Pseudomonas aeruginosa by sputum culture].
Topics: Adult; Aged; Amikacin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Imipenem; Japan; Klebsiella pneumoniae; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Prognosis; Pseudomonas aeruginosa; Retrospective Studies; Sputum; Staphylococcus aureus; Time Factors | 2007 |
A case of Acinetobacter calcoaceticus pneumonia.
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Amikacin; Ceftriaxone; Community-Acquired Infections; Diagnosis, Differential; Humans; Male; Pneumonia, Bacterial | 1995 |
Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Kidney; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rats; Rats, Wistar | 1997 |
Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Creatinine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Lung; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rats; Rats, Mutant Strains; Time Factors; Treatment Outcome | 1998 |
Spontaneous remission in myelodysplastic syndrome.
Topics: Aged; Amikacin; Anemia, Refractory, with Excess of Blasts; Bone Marrow; Ceftazidime; Chromosomes, Human, Pair 21; Cytokines; Drug Therapy, Combination; Humans; Male; Pneumonia, Bacterial; Recurrence; Remission, Spontaneous; Trisomy | 1999 |
Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Imipenem; Lung; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar | 1999 |
Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Doxycycline; Drug Therapy, Combination; Female; Imipenem; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Survival Analysis; Thienamycins; Time Factors | 2000 |
In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia.
Topics: Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Drug Therapy, Combination; Female; Imipenem; Levofloxacin; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Bacterial; Thienamycins | 2000 |
Aerosolized amikacin in the treatment of Pseudomonas pneumonia in the nursing home setting.
Topics: Administration, Inhalation; Aerosols; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Homes for the Aged; Humans; Male; Nursing Homes; Pneumonia, Bacterial; Pseudomonas Infections | 2001 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |
[Soft-tissue abscess caused by Rhodococcus equi in a patient on hemodialysis].
Topics: Abscess; Actinomycetales Infections; Adrenal Cortex Hormones; Aged; Amikacin; Anti-Glomerular Basement Membrane Disease; Ciprofloxacin; Clarithromycin; Cyclophosphamide; Disease Susceptibility; Drug Therapy, Combination; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Opportunistic Infections; Pneumonia, Bacterial; Renal Dialysis; Rhodococcus equi; Thigh | 2001 |